Aimei Health Faces Nasdaq Noncompliance Over Delayed 10-K

An announcement from Aimei Health Technology Co., Ltd ( (AFJK) ) is now available.

On April 17, 2026, Aimei Health Technology Co., Ltd received a Nasdaq notice stating it was non-compliant with listing rules after failing to file its Form 10‑K for the year ended Dec. 31, 2025, which had been due March 31 and for which it had lodged a late‑filing notice on April 1. The April 21, 2026 announcement confirms there is no immediate impact on the trading of its Nasdaq‑listed securities, but the company faces a potential delisting if it does not file the report or secure and execute an acceptable compliance plan within Nasdaq’s 60‑ to 180‑day remediation window.

Under Nasdaq procedures, Aimei has 60 days from the April 17, 2026 notice either to file the overdue annual report or submit a remediation plan, with up to 180 days from the original due date available if the plan is accepted. The company says it is working to complete the filing and aims to regain compliance, a process closely watched by investors because prolonged non‑compliance or an unsuccessful appeal could ultimately jeopardize its Nasdaq listing and impair its ability to execute its blank check acquisition strategy.

More about Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd is a Cayman Islands‑incorporated blank check company formed to pursue a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. While not restricted to any sector or geography, it plans to target companies focused on healthcare innovation, positioning itself as a special purpose acquisition vehicle in the health sector deal market.

Average Trading Volume: 22,564

Technical Sentiment Signal: Strong Buy

Current Market Cap: $313.4M

Learn more about AFJK stock on TipRanks’ Stock Analysis page.